years in solvent extraction, solution chemistry thermodynamics, and the analysis of high-level radioactive wastes. In the past decade, he has been extensively involved with the Analytical Development Section of the Savannah River Technology Center where he has participated in finding solutions to the many problems related to the analysis of high-level waste tanks and the start-up of the Defense Waste Processing Facility vitrification process. He has participated in review panels for the Characterization, Monitoring and Sensor Technology program for DOE and for the Basic Chemical Sciences panel for the EPA. His main pedagogical interests are in developing experiments involving the use of chemical instrumentation in solving chemical and environmental analytical problems. These experiments emphasize the use of computer based data analyses to answer chemical questions. Recent work has included using the worldwide web as an augmentation to classroom activities. Dr. Kinard received his B.S. from Duke University and his Ph.D. from the University of South Carolina.
Francis Livens is professor of radiochemistry and research director of the Dalton Nuclear Institute in the University of Manchester. He received his Ph.D. in plutonium geochemistry from the University of Glasgow in 1985 and joined the University of Manchester in 1991 where, in 1999, he was the founding director of the Centre for Radiochemistry Research (CRR). He has worked in radionuclide geochemistry, aqueous speciation and spectroscopy, and radioactive waste disposal, with a particular interest in the actinide elements. Dr. Livens provides advice to the U.K. government on nuclear and related matters, and is a member of the Advisory Committee on Radioactive Waste Management.
Tim McCarthy, a two-time graduate of the University of Liverpool, U.K., with a B.Sc. in chemistry, followed by a Ph.D. in organic chemistry in 1989. Dr. McCarthy earned an MBA at Washington University in St. Louis, Missouri, in 2000. He has published more than 45 papers and contributed to four books. He is currently the president of the Academy of Molecular Imaging and founding director and past-president of the Society of Non-Invasive Imagining in Drug Development. In his role at Pfizer Global Research and Development, Dr. McCarthy is responsible for the application of imaging techniques to facilitate the prosecution of compounds in the development portfolio and across all therapeutic areas. Additionally, his role is focused on the application of innovative imaging technologies to accelerate drug development. Since 2003, Dr. McCarthy has held senior management roles with Pfizer Global R&D. Prior to joining the company, he held a number of academic and industry positions in the field of positron emission tomog-